Tumor gangliosides accelerate murine tumor angiogenesis

Angiogenesis

Volumn 17, Issue 3, 2014, Pages 563-571

  Liu, Yihui ^a,b   Wondimu, Assefa ^a   Yan, Su ^a   Bobb, Daniel ^a   Ladisch, Stephan ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Gangliosides; Shedding; Tumor angiogenesis; Vascular endothelial cells

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GM3; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DEPLETION; DISEASE ASSOCIATION; EMBRYO; ENRICHMENT CULTURE; FEMALE; LIPID ANALYSIS; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

MURINAE;

ANIMALS; CARCINOGENESIS; CELL PROLIFERATION; FEMALE; GANGLIOSIDES; IMMUNOHISTOCHEMISTRY; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903906267     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9403-4     Document Type: Article

References (48)

1. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
2. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
3. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
4. Roodink I, Leenders WP (2010) Targeted therapies of cancer: angiogenesis inhibition seems not enough. Cancer Lett 299:1-10
5. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307
6. Shojaei F (2012) Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 320:130-137
7. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375-379
8. Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann NY Acad Sci 995:151-161
9. Kim Y, Stolarska MA, Othmer HG (2011) The role of the microenvironment in tumor growth and invasion. Prog Biophys Mol Biol 106:353-379
10. Zhang J, Liu J (2013) Tumor stroma as targets for cancer therapy. Pharmacol Ther 137:200-215
11. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442-447
12. Bernstein LR, Liotta LA (1994) Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 6:106-113
13. Ladisch S, Gillard B, Wong C, Ulsh L (1983) Shedding and immunoregulatory activity of yac-1 lymphoma cell gangliosides. Cancer Res 43:3808-3813
14. Olshefski R, Ladisch S (1996) Intercellular transfer of shed tumor cell gangliosides. FEBS Lett 386:11-14
15. Li R, Liu Y, Ladisch S (2001) Enhancement of epidermal growth factor signaling and activation of src kinase by gangliosides. J Biol Chem 276:42782-42792
16. Hakomori Si SI (2002) The glycosynapse. Proc Natl Acad Sci USA 99:225-232
17. Liu Y, Li R, Ladisch S (2004) Exogenous ganglioside gd1a enhances epidermal growth factor receptor binding and dimerization. J Biol Chem 279:36481-36489
18. Liu Y, McCarthy J, Ladisch S (2006) Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling. Cancer Res 66:10408-10414
19. Regina Todeschini A, Hakomori SI (2008) Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780:421-433
20. Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH (2009) Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. Glycobiology 19:229-239
21. Seyfried TN, Mukherjee P (2010) Ganglioside GM3 is antiangiogenic in malignant brain cancer. J Oncol 2010:961243
22. Wang H, Isaji T, Satoh M, Li D, Arai Y, Gu J (2013) Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model. Urology 81(210):e211-e215
23. Ladisch S, Kitada S, Hays EF (1987) Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest 79:1879-1882
24. Deng W, Li R, Ladisch S (2000) Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst 92:912-917
25. Katano M, Irie RF (1984) Human monoclonal antibody to tumor-associated ganglioside gd2: suppressed growth of human melanoma in nude mice. Immunol Lett 8:169-174
26. Gullino PM (1995) Prostaglandins and gangliosides of tumor microenvironment: their role in angiogenesis. Acta Oncol 34:439-441
27. Alessandri G, Cornaglia-Ferraris P, Gullino PM (1997) Angiogenic and angiostatic microenvironment in tumors-role of gangliosides. Acta Oncol 36:383-387
28. Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN (2008) Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. J Lipid Res 49:929-938
29. Liu Y, Yan S, Wondimu A, Bob D, Weiss M, Sliwinski K, Villar J, Notario V, Sutherland M, Colberg-Poley AM, Ladisch S (2010) Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogene 29:3297-3306
30. Garlanda C, Berthier R, Garin J, Stoppacciaro A, Ruco L, Vittet D, Gulino D, Matteucci C, Mantovani A, Vecchi A, Dejana E (1997) Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: a useful reage for identifying and characterizing blood vessels and hematopoietic precursors. Eur J Cell Biol 73:368-377
31. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8
32. Ladisch S, Gillard B (1985) A solvent partition method for microscale ganglioside purification. Anal Biochem 146:220-231
33. Carvalho JF, Blank M, Shoenfeld Y (2007) Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 27:246-256
34. Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343-353
35. Folkman J (1974) Tumor angiogensis: role in regulation of tumor growth. Symp Soc Dev Biol 30:43-52
36. Ecsedy JA, Holthaus KA, Yohe HC, Seyfried TN (1999) Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice. J Neurochem 73:254-259
37. Ziche M, Alessandri G, Gullino PM (1989) Gangliosides promote the angiogenic response, laboratory investigation. J Tech Methods Pathol 61:629-634
38. Ladisch S, Becker H, Ulsh L (1992) Immunosuppression by human gangliosides: I relationship of carbohydrate structure to the inhibition of t cell responses. Biochim Biophys Acta 1125:180-188
39. Ladisch S, Li R, Olson E (1994) Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc Natl Acad Sci USA 91:1974-1978
40. Liu Y, Su Y, Wiznitzer M, Epifano O, Ladisch S (2008) Ganglioside depletion and egf responses of human GM3 synthase-deficient fibroblasts. Glycobiology 18:593-601
41. Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, Wang H, Wiznitzer M, Gurtz K, Verganelaki A, Pryde A, Patton MA, Dwek RA, Butters TD, Platt FM, Crosby AH (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36:1225-1229
42. Ladisch S, Wu ZL (1985) Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma. Lancet 1:136-138
43. Bernhard H, Meyer zum Buschenfelde KH, Dippold WG (1989) Ganglioside GD3 shedding by human malignant melanoma cells. Int J Cancer. Journal International du cancer 44:155-160
44. Valentino L, Moss T, Olson E, Wang HJ, Elashoff R, Ladisch S (1990) Shed tumor gangliosides and progression of human neuroblastoma. Blood 75:1564-1567
45. Portoukalian J, David MJ, Gain P, Richard M (1993) Shedding of GD2 ganglioside in patients with retinoblastoma. Int J Cancer 53:948-951
46. Merritt WD, Der-Minassian V, Reaman GH (1994) Increased GD3 ganglioside in plasma of children with t-cell acute lymphoblastic leukemia. Leukemia 8:816-822
47. Chang F, Li R, Ladisch S (1997) Shedding of gangliosides by human medulloblastoma cells. Exp Cell Res 234:341-346
48. Uzzo RG, Clark PE, Rayman P, Bloom T, Rybicki L, Novick AC, Bukowski RM, Finke JH (1999) Alterations in nfkappab activation in t lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst 91:718-721